Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
J Cell Biol ; 149(2): 379-96, 2000 Apr 17.
Artigo em Inglês | MEDLINE | ID: mdl-10769030

RESUMO

Vesicular transport proteins package classical neurotransmitters for regulated exocytotic release, and localize to at least two distinct types of secretory vesicles. In PC12 cells, the vesicular acetylcholine transporter (VAChT) localizes preferentially to synaptic-like microvesicles (SLMVs), whereas the closely related vesicular monoamine transporters (VMATs) localize preferentially to large dense core vesicles (LDCVs). VAChT and the VMATs contain COOH-terminal, cytoplasmic dileucine motifs required for internalization from the plasma membrane. We now show that VAChT undergoes regulated phosphorylation by protein kinase C on a serine (Ser-480) five residues upstream of the dileucine motif. Replacement of Ser-480 by glutamate, to mimic the phosphorylation event, increases the localization of VAChT to LDCVs. Conversely, the VMATs contain two glutamates upstream of their dileucine-like motif, and replacement of these residues by alanine conversely reduces sorting to LDCVs. The results provide some of the first information about sequences involved in sorting to LDCVs. Since the location of the transporters determines which vesicles store classical neurotransmitters, a change in VAChT trafficking due to phosphorylation may also influence the mode of transmitter release.


Assuntos
Proteínas de Transporte/metabolismo , Grânulos Citoplasmáticos/fisiologia , Grânulos Citoplasmáticos/ultraestrutura , Proteínas de Membrana Transportadoras , Neuropeptídeos , Proteínas de Transporte Vesicular , Substituição de Aminoácidos , Animais , Células COS , Proteínas de Transporte/química , Proteínas de Transporte/genética , Fracionamento Celular , Membrana Celular/metabolismo , Centrifugação com Gradiente de Concentração , Clonagem Molecular , Ácido Glutâmico , Leucina , Glicoproteínas de Membrana/metabolismo , Mutagênese Sítio-Dirigida , Células PC12 , Fosforilação , Mutação Puntual , Proteína Quinase C/metabolismo , Ratos , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Serina , Serotonina/metabolismo , Vesículas Sinápticas/fisiologia , Vesículas Sinápticas/ultraestrutura , Proteínas Vesiculares de Transporte de Acetilcolina , Proteínas Vesiculares de Transporte de Aminas Biogênicas
2.
Neuron ; 31(3): 453-62, 2001 Aug 16.
Artigo em Inglês | MEDLINE | ID: mdl-11516401

RESUMO

Endocannabinoids are retrograde messengers released by neurons to modulate the strength of their synaptic inputs. Endocannabinoids are thought to mediate the suppression of GABA release that follows depolarization of a hippocampal CA1 pyramidal neuron-termed "depolarization-induced suppression of inhibition" (DSI). Here, we report that DSI is absent in mice which lack cannabinoid receptor-1 (CB1). Pharmacological and kinetic evidence suggests that CB1 activation inhibits presynaptic Ca2+ channels through direct G protein inhibition. Paired recordings show that endocannabinoids selectively inhibit a subclass of synapses distinguished by their fast kinetics and large unitary conductance. Furthermore, cannabinoid-sensitive inputs are unusual among central nervous system synapses in that they use N- but not P/Q-type Ca2+ channels for neurotransmitter release. These results indicate that endocannabinoids are highly selective, rapid modulators of hippocampal inhibition.


Assuntos
Canabinoides/metabolismo , Hipocampo/fisiologia , Terminações Pré-Sinápticas/fisiologia , Células Piramidais/fisiologia , Receptores de Droga/fisiologia , Receptores Pré-Sinápticos/fisiologia , Animais , Bloqueadores dos Canais de Cálcio/farmacologia , Canais de Cálcio/fisiologia , Moduladores de Receptores de Canabinoides , Colforsina/farmacologia , Endocanabinoides , Feminino , Proteínas de Ligação ao GTP/metabolismo , Técnicas In Vitro , Interneurônios/fisiologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Técnicas de Patch-Clamp , Terminações Pré-Sinápticas/efeitos dos fármacos , Células Piramidais/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Receptores de Canabinoides , Receptores de Droga/deficiência , Receptores de Droga/genética , Receptores Pré-Sinápticos/efeitos dos fármacos , Transdução de Sinais
3.
Neuroscience ; 90(4): 1157-65, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10338286

RESUMO

Long-term potentiation, a persistent increase in synaptic efficacy, may require a retrograde signal originating in the postsynaptic cell that induces an increase in presynaptic neurotransmitter release. We have constructed a mouse homozygous for a targeted null mutation in the endothelial isoform of nitric oxide synthase and report that long-term potentiation in the CA1 region of these mice is entirely absent under weak stimulation conditions. Application of a membrane-permeant guanosine-3',5'-cyclic monophosphate analogue during tetanus fails to compensate for this deficit, suggesting that nitric oxide produced by endothelial nitric oxide synthase may affect long-term potentiation through a cascade that does not include guanylyl cyclase. We also report that strong tetanic stimulation can induce robust long-term potentiation in these mice which is not blocked by pharmacological inhibitors of nitric oxide synthase. Furthermore, mice lacking endothelial nitric oxide synthase show no shift in the frequency-response curve for the induction of long-term potentiation. Basal synaptic transmission, paired-pulse facilitation and the electrical properties of CA1 cells in these mice were similar to controls. These results support a selective role for endothelial nitric oxide synthase in long-term potentiation, but also demonstrate that nitric oxide synthase is not involved in this process under all conditions.


Assuntos
Hipocampo/fisiopatologia , Potenciação de Longa Duração/fisiologia , Óxido Nítrico Sintase/deficiência , Animais , GMP Cíclico/análogos & derivados , GMP Cíclico/farmacologia , Estimulação Elétrica/métodos , Potenciais Pós-Sinápticos Excitadores/fisiologia , Técnicas In Vitro , Potenciação de Longa Duração/efeitos dos fármacos , Camundongos , Camundongos Knockout/genética , Neurônios/fisiologia , Óxido Nítrico Sintase/genética , Óxido Nítrico Sintase Tipo II , Óxido Nítrico Sintase Tipo III , Transmissão Sináptica/fisiologia
4.
J Agric Food Chem ; 48(3): 944-50, 2000 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10725179

RESUMO

The photolysis of metolachlor [2-chloro-N-(2-ethyl-6-methylphenyl)-N-(2-methoxy-1-methylethyl) acetamide] in a sunlight simulator under actinic radiation was investigated. The focus of the study was to determine the extent of monochloroacetic acid (MCA) production. MCA was concentrated and derivatized from photolysate as the n-propyl ester using propanol and sulfuric acid and then identified as the ester using GC/MS and GC/ECD. On the basis of regression analysis, it was shown that the direct photodegradation of approximately 10 microM metolachlor followed pseudo-first-order kinetics with respect to the metolachlor concentration, and the half-life of the herbicide ( approximately 74 h) was independent of the pH of the medium. Photolysis in synthetic field water (SFW) resulted in a significant reduction of photolysis time (t(1/2) approximately 9 h). Direct photolysis experiments indicate a 5.19 +/- 0.81% (n=3) conversion of metolachlor to MCA, while photolysis in synthetic field water and in a Don River water sample resulted in 29.8 +/- 4.6% (n = 3) and 12.6 +/- 4.1% (n = 3) conversion, respectively; MCA was shown to be hydrolytically stable over the time course of the photoreaction. The photodegradation of alachlor, butachlor and a model chloroacetanilide, 2-chloro-N-methylacetanilide, in SFW were also investigated.


Assuntos
Acetamidas/química , Acetatos/análise , Herbicidas/química , Fotólise , Acetatos/isolamento & purificação , Poluição Ambiental/prevenção & controle , Humanos , Luz Solar
6.
Ulster Med J ; 47 Suppl 1: 15-6, 1978.
Artigo em Inglês | MEDLINE | ID: mdl-307851
9.
Nature ; 410(6828): 588-92, 2001 Mar 29.
Artigo em Inglês | MEDLINE | ID: mdl-11279497

RESUMO

Marijuana affects brain function primarily by activating the G-protein-coupled cannabinoid receptor-1 (CB1), which is expressed throughout the brain at high levels. Two endogenous lipids, anandamide and 2-arachidonylglycerol (2-AG), have been identified as CB1 ligands. Depolarized hippocampal neurons rapidly release both anandamide and 2-AG in a Ca2+-dependent manner. In the hippocampus, CB1 is expressed mainly by GABA (gamma-aminobutyric acid)-mediated inhibitory interneurons, where CB1 clusters on the axon terminal. A synthetic CB1 agonist depresses GABA release from hippocampal slices. These findings indicate that the function of endogenous cannabinoids released by depolarized hippocampal neurons might be to downregulate GABA release. Here we show that the transient suppression of GABA-mediated transmission that follows depolarization of hippocampal pyramidal neurons is mediated by retrograde signalling through release of endogenous cannabinoids. Signalling by the endocannabinoid system thus represents a mechanism by which neurons can communicate backwards across synapses to modulate their inputs.


Assuntos
Ácidos Araquidônicos , Canabinoides/metabolismo , Hipocampo/metabolismo , Receptores de Droga/metabolismo , Sinapses/metabolismo , Animais , Benzoxazinas , Moduladores de Receptores de Canabinoides , Canabinoides/antagonistas & inibidores , Endocanabinoides , Glicerídeos/metabolismo , Técnicas In Vitro , Morfolinas/farmacologia , Naftalenos/farmacologia , Inibição Neural , Piperidinas/farmacologia , Células Piramidais/efeitos dos fármacos , Células Piramidais/metabolismo , Pirazóis/farmacologia , Ratos , Ratos Sprague-Dawley , Receptores de Canabinoides , Receptores de Droga/agonistas , Receptores de Droga/antagonistas & inibidores , Receptores de Glutamato Metabotrópico/antagonistas & inibidores , Receptores de Glutamato Metabotrópico/metabolismo , Rimonabanto , Transdução de Sinais , Sinapses/efeitos dos fármacos , Transmissão Sináptica , Ácido gama-Aminobutírico/metabolismo
10.
Clin Orthop Relat Res ; (170): 231-7, 1982 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-7127952

RESUMO

Auscultation of human joints is a rarely practiced art. Many attempts have been made to develop a technique with objective parameters but none are sufficiently sensitive for clinical use. This article reviews the history of auscultation as applied to human joints. An acoustic system was critically evaluated and attempts were made to exclude skin friction and ambient noise. Human joint sounds were found to be at the low end of the acoustic range. The microphone was a poor transducer in terms of frequency and dynamic sensitivities for use with human joint emission because of the large acoustic impedance. Many of the problems encountered by workers in this field might be due to failure to appreciate the limitation of detection apparatus.


Assuntos
Auscultação/métodos , Artropatias/diagnóstico , Articulações , Auscultação/instrumentação , Humanos
11.
J Neurosci ; 20(18): 6888-97, 2000 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-10995833

RESUMO

The neurotrophin BDNF has been shown to modulate long-term potentiation (LTP) at Schaffer collateral-CA1 hippocampal synapses. Mutants in the BDNF receptor gene trkB and antibodies to its second receptor p75NTR have been used to determine the receptors and cells involved in this response. Inhibition of p75NTR does not detectably reduce LTP or affect presynaptic function, but analyses of newly generated trkB mutants implicate TrkB. One mutant has reduced expression in a normal pattern of TrkB throughout the brain. The second mutant was created by cre-loxP-mediated removal of TrkB in CA1 pyramidal neurons of this mouse. Neither mutant detectably impacts survival or morphology of hippocampal neurons. TrkB reduction, however, affects presynaptic function and reduces the ability of tetanic stimulation to induce LTP. Postsynaptic glutamate receptors are not affected by TrkB reduction, indicating that BDNF does not modulate plasticity through postsynaptic TrkB. Consistent with this, elimination of TrkB in postsynaptic neurons does not affect LTP. Moreover, normal LTP is generated in the mutant with reduced TrkB by a depolarization-low-frequency stimulation pairing protocol that puts minimal demands on presynaptic terminal function. Thus, BDNF appears to act through TrkB presynaptically, but not postsynaptically, to modulate LTP.


Assuntos
Hipocampo/metabolismo , Potenciação de Longa Duração/genética , Terminações Pré-Sinápticas/metabolismo , Receptor de Fator de Crescimento Neural/metabolismo , Receptor trkB/metabolismo , Animais , Antígenos de Diferenciação/metabolismo , Axônios/metabolismo , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina , Proteínas Quinases Dependentes de Cálcio-Calmodulina/genética , Hipocampo/citologia , Técnicas In Vitro , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Plasticidade Neuronal/genética , Técnicas de Patch-Clamp , Células Piramidais/metabolismo , RNA Mensageiro/biossíntese , Receptor de Fator de Crescimento Neural/antagonistas & inibidores , Receptor trkB/deficiência , Receptor trkB/genética , Receptores de Glutamato/metabolismo , Transdução de Sinais/genética , Células-Tronco
12.
J Ir Med Assoc ; 61(378): 427-9, 1968 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-5703395
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA